Month: August 2024

  • 5 Key Insights On The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market 2024

    5 Key Insights On The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2024, the topical drugs contract development and manufacturing organization (CDMO) market is expected to show significant growth in the forecast period.

    The topical drugs contract development and manufacturing organization (CDMO) market has experienced significant growth recently.

    • Market Size and Growth:
      • Grew from $45.47 billion in 2023 to $52.9 billion in 2024, reflecting a CAGR of 16.3%.
      • Expected to reach $97.26 billion by 2028, with a CAGR of 16.4%.

    Factors Driving Historic Growth
    Several factors contributed to the market’s growth during the historic period.

    • Chronic Disease Prevalence: Increased incidence of chronic skin conditions.
    • Advanced Drug Delivery Technologies: Innovations in how drugs are delivered topically.
    • Cost-Efficient Outsourcing: Pharmaceutical companies outsourcing to CDMOs for cost savings.
    • Regulatory Demands: Stringent regulations requiring specialized manufacturing processes.
    • Growth in Dermatology and Cosmetics: Rising demand for dermatological and cosmetic products.

    Future Growth Drivers
    The forecast period predicts continued robust growth due to several key factors.

    • Personalized Medicine: Increased focus on tailored treatments for individuals.
    • Biologics Expansion: Growth in biologic drugs requiring specialized manufacturing.
    • Increased R&D Investments: More funding towards research and development in topical drugs.
    • Rising Skin Disorder Prevalence: More cases of skin conditions driving demand for treatments.
    • Advanced Manufacturing Technologies: Technological advancements enhancing production efficiency.

    View More On The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/topical-drugs-contract-development-and-manufacturing-organization-cdmo-global-market-report

    Major Trends Shaping the Market
    Several trends are expected to shape the market landscape in the coming years.

    • Innovative Formulations: Demand for new and effective drug formulations.
    • Advancements in Drug Delivery Technologies: Continued innovation in how drugs are delivered.
    • Investment in Dermatological Research: Increased funding for research in skin-related treatments.
    • Surge in Outsourcing: Pharmaceutical companies increasingly outsourcing to CDMOs.
    • Focus on Personalized Medicine: Growing emphasis on customized treatment options.
    • Stringent Regulatory Requirements: Need for compliance with complex regulations.
    • Consumer Preference for OTC Products: Growing demand for over-the-counter skincare products.

    Impact of Rising Skin Disease Prevalence
    The increasing prevalence of skin diseases is a significant driver for the market.

    • Environmental Factors: Pollution and UV exposure contributing to skin conditions.
    • Lifestyle Changes: Modern lifestyle factors leading to higher incidence of skin issues.
    • Microbial Infections: Increased cases of infections affecting the skin.
    • Targeted Therapies: CDMOs developing targeted treatments to manage and reduce skin diseases.
    • Case Study: Significant increase in skin melanoma cases in Australia from 2019 to 2023, highlighting the growing need for effective treatments.

    Major Players in the Market
    Key companies are driving innovation and growth in the topical drugs CDMO market.

    • Notable Companies:
      • Evonik Industries AG
      • Eurofins Scientific SE
      • SGS SA
      • The Lubrizol Corporation
      • Lonza Group AG
      • Catalent Inc.
      • Bora Pharmaceuticals Co. Ltd.
      • Recipharm AB
      • Pierre Fabre S.A.
      • Contract Pharmaceuticals Limited
      • UPM Pharmaceuticals Inc.
      • CoreRx Inc.
      • Halo Pharmaceutical Inc.
      • NextPharma Technologies Holding Limited
      • Tedor Pharma Inc.

    Focus on State-of-the-Art Manufacturing Facilities
    Companies are investing in advanced manufacturing facilities to stay competitive.

    • Example: SOHM Inc. launched a new CDMO GMP manufacturing facility in Carlsbad, enhancing its capacity for manufacturing topical products.

    Strategic Acquisitions to Expand Capabilities
    Mergers and acquisitions are playing a crucial role in market expansion.

    • Example: In April 2024, CoreRx Inc. acquired Societal CDMO Inc. for $130 million, enhancing its CDMO capabilities and market share.

    Market Segmentation
    The topical drugs CDMO market is segmented by product type, service type, therapeutic area, and end-use.

    • Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products.
    • Service Type: Contract Development, Contract Manufacturing.
    • Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas.
    • End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses.

    Regional Insights
    Asia-Pacific was the largest region in the topical drugs CDMO market in 2023, indicating significant regional opportunities for growth.

    Request A Sample Of The Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15942&type=smp

  • How Is The Surgical Robot Accessories Market Expected To Grow Through 2024-2033

    How Is The Surgical Robot Accessories Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Surgical Robot Accessories Global Market Report 2024, the surgical robot accessories market is expected to show promising growth in the forecast period.

    Market Size and Growth

    • The surgical robot accessories market is experiencing significant growth.
    • 2023 Market Size: $4.31 billion
    • 2024 Market Size: $4.92 billion
    • CAGR (2023-2024): 14.4%
    • 2028 Market Size: $8.50 billion
    • CAGR (2024-2028): 14.6%

    Factors Driving Historical Growth
    Miniaturization and Material Science

    • Advances in miniaturization and material science have enhanced the precision and functionality of surgical robot accessories.

    Connectivity and Data Integration

    • Improved connectivity and data integration have streamlined surgical procedures and improved outcomes.

    Healthcare Policies and Reimbursements

    • Favorable healthcare policies and reimbursements have boosted the adoption of robotic surgery.

    Safety and Quality Standards

    • Enhanced safety and quality standards have increased trust in robotic surgical systems.

    Surgeon and Patient Demand

    • Growing demand from both surgeons and patients for minimally invasive procedures has driven market growth.

    Projected Growth Factors
    Increasing Adoption of Robotic Surgery

    • The rise in robotic surgery adoption is a key driver of future market growth.

    Healthcare Infrastructure Development

    • Ongoing development of healthcare infrastructure supports the expansion of robotic surgery.

    Cost Reduction and Efficiency

    • Reduced costs and increased efficiency of robotic systems encourage their use.

    Training and Education Programs

    • Enhanced training and education programs are facilitating the adoption of robotic surgery.

    Economic and Geopolitical Stability

    • Stable economic and geopolitical conditions favor market expansion.

    View More On The Surgical Robot Accessories Market Report 2024 – https://www.thebusinessresearchcompany.com/report/surgical-robot-accessories-global-market-report

    Emerging Trends
    Miniaturization and Wireless Connectivity

    • Continued miniaturization and the introduction of wireless connectivity are expected to revolutionize the market.

    Interoperability and Modular Design

    • Interoperability and modular design improvements will enhance the versatility of surgical robots.

    Sterilization and Reusability

    • Advances in sterilization and reusability will reduce costs and increase efficiency.

    Haptic Feedback and Tactile Sensing

    • Enhanced haptic feedback and tactile sensing will improve surgical precision.

    Voice and Gesture Control

    • The integration of voice and gesture control will streamline robotic surgery procedures.

    Rising Number of Surgical Procedures

    Increasing Prevalence of Chronic Diseases

    • A rise in chronic diseases necessitates more surgical interventions.

    Advancements in Medical Technology

    • Technological advancements are making surgeries more effective and accessible.

    Preference for Minimally Invasive Surgeries

    • Growing preference for minimally invasive surgeries drives demand for surgical robot accessories.

    Major Companies in the Market

    • Key Players: Johnson & Johnson, Stryker Corporation, Titan Medical Inc., Zimmer Biomet Holdings Inc., Smith & Nephew plc, Sina Robotics and Medical Innovators Co Ltd., Intuitive Surgical Inc., MicroPort Scientific Corporation, Renishaw plc, CMR Surgical Limited, Noah Medical Inc., THINK Surgical Inc., Vicarious Surgical Inc., Distalmotion SA, OmniGuide Holdings Inc., CUREXO Inc., Human Xtensions Ltd., OMNIlife Science Inc., Moon Surgical Inc., Verb Surgical Inc., Corindus Vascular Robotics Inc., AdEchoTech, Biobot Surgical Pte Ltd., Medicaroid Corporation, Asensus Surgical Inc.

    Technological Advancements
    Robotic Microsurgery Simulators

    • Companies are developing advanced robotic microsurgery simulators for training purposes.
    • Example: Medical Microinstruments (MMI) SpA’s Symani Surgical System Simulator launched in May 2022, offering lifelike haptic feedback and advanced virtual reality scenarios.

    Strategic Acquisitions
    Telix Pharmaceuticals and Lightpoint Medical

    • In November 2023, Telix Pharmaceuticals acquired Lightpoint Medical for $35 million.
    • This acquisition aimed to enhance Telix’s position in molecularly targeted radiation (MTR) therapies.

    Market Segmentation
    By Type

    • Instrument
    • Accessories

    By Application

    • Orthopedics
    • Neurology
    • Urology
    • Gynecology
    • Other Applications

    By End-Use

    • Inpatient
    • Outpatient

    Regional Insights

    • Largest Market (2023): North America
    • Fastest-Growing Region (Forecast Period): Asia-Pacific

    The surgical robot accessories market is poised for continued growth, driven by technological advancements, increased surgical procedures, and strategic industry developments.

    Request A Sample Of The Global Surgical Robot Accessories Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15939&type=smp

  • Surgery Tables Global Market Outlook 2024-2033: Size And Growth Rate Analysis

    Surgery Tables Global Market Outlook 2024-2033: Size And Growth Rate Analysis

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Market Growth Trends

    • Recent Growth:
      • The surgery table market size grew from $1.05 billion in 2023 to $1.12 billion in 2024.
      • This growth represents a compound annual growth rate (CAGR) of 6.9%.
      • Growth drivers:
        • Increase of non-profit organizations.
        • Expansion of hospital infrastructure in developing countries.
        • Higher incidence of cardiovascular disorders.
        • Popularity of contemporary operating tables.
        • Prevalence of targeted diseases.
    • Future Projections:
      • Expected to reach $1.48 billion in 2028.
      • Anticipated CAGR of 7.2%.
      • Forecast growth factors:
        • Rising number of surgeries.
        • Increase in ambulatory surgical centers.
        • Growing demand for minimally invasive surgeries.
        • Rising cases of trauma and injuries globally.
        • Need for replacing outdated surgery tables.
      • Major trends:
        • Integration of advanced imaging technologies.
        • Rapid advancements in surgical tables.
        • Product innovation.
        • Technological advancements.
        • Robust investments in healthcare infrastructure.

    View More On The Surgery Tables Market Report 2024 – https://www.thebusinessresearchcompany.com/report/surgery-tables-global-market-report

    Impact of Rising Surgical Procedures

    • Driving Factors:
      • Increasing surgical procedures boost market growth.
      • Surgeries require stable, adjustable, and sterile tables for optimal patient positioning and surgical team accessibility.
      • Example: In 2021, 6,541 living donor transplants were performed in the U.S., a 14.2% increase from 2020.

    Key Market Players

    • Major Companies:
      • Stryker Corp.
      • Getinge AB
      • TRUMPF Medizin Systeme GmbH + Co. KG
      • Steris Corporation
      • Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
      • Hillrom Holdings Inc.
      • Mizuho OSI Inc.
      • Alvo Medical
      • Lojer Group
      • STILLE AB
      • UFSK-International OSYS GmbH
      • Denyers Pty. Ltd.
      • Infimed Sp. z o.o.
      • AGA Sanitätsartikel GmbH
      • Nuvo Inc.
      • Allen Medical Systems Inc.
      • Medifa GmbH
      • OPT SurgiSystems Srl
      • Eschmann Holdings Ltd.
      • NUVO Surgical

    Innovative Mobile Surgical Tables

    • Product Development:
      • Companies are innovating with mobile surgical tables to meet diverse surgical needs.
      • Example: In March 2024, Getinge launched the Corin operating table.
        • Features:
          • Intuitive controls.
          • Advanced feedback lighting.
          • Collision detection.
          • Tipping prevention.
          • Overload detection.
          • Customizable sequences and preset surgical positions for flexibility and efficiency.

    Strategic Acquisitions

    • Notable Acquisition:
      • In December 2021, Baxter International Inc. acquired Hillrom for $12.5 billion.
      • Purpose:
        • Broaden product portfolio.
        • Enhance expertise in hospital equipment and digital health.
        • Strengthen position as a global leader in medical technology.
      • Hillrom specializes in manufacturing surgery tables.

    Market Segmentation

    • By Type:
      • Powered
      • Non-Powered
    • By Product:
      • General Surgical Beds
      • Specialty Surgical Beds
      • Radiolucent Surgical Beds
      • Pediatric Surgical Beds
    • By Material:
      • Metal
      • Composite
    • By End Users:
      • Hospitals
      • Ambulatory Surgery Centers
      • Other End Users
    • Geographical Insights:
      • North America was the largest region in the surgery table market in 2023.

    Request A Sample Of The Global Surgery Tables Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15938&type=smp

  • Subcutaneous Immunoglobulin (SCIG) Market Report 2024: Market Size, Drivers, And Trends

    Subcutaneous Immunoglobulin (SCIG) Market Report 2024: Market Size, Drivers, And Trends

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Current Market Overview

    • The subcutaneous immunoglobulin market is expanding swiftly.
    • 2023 Market Size: $11.19 billion.
    • 2024 Market Size: Expected to reach $12.72 billion, with a CAGR of 13.7%.
    • Growth Drivers:
      • Increased prevalence of immunodeficiency disorders.
      • Rise in patient preference for home-based care.
      • Enhanced therapeutic efficacy.
      • Growth in awareness and diagnosis rates.
      • Favorable reimbursement policies.

    Future Market Projections

    • The market will continue to grow significantly.
    • 2028 Market Size: Expected to reach $21.38 billion, with a CAGR of 13.9%.
    • Growth Drivers:
      • Growing prevalence of neurological disorders.
      • Increasing prevalence of autoimmune diseases.
      • Rising awareness and acceptance of immunoglobulin therapy.
      • Expanding applications in neurology and dermatology.
      • Expansion of healthcare facilities.
    • Major Trends:
      • Advancements in drug delivery systems.
      • Increasing demand for home infusion therapies.
      • Developments in antibody therapy.
      • Innovations in formulations and SCIG.

    View More On The Subcutaneous Immunoglobulin (SCIG) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

    Impact of Secondary Immunodeficiency Diseases

    Growing Prevalence and Market Impact

    • Secondary Immunodeficiency Diseases: Conditions caused by external factors like aging, immunosuppressive treatments, and environmental toxins.
    • Impact: These diseases necessitate subcutaneous immunoglobulin therapy, which strengthens the immune system and prevents infections.
    • Example:
      • UK Health Security Agency Report (October 2023): 3,805 new HIV diagnoses in England in 2022, a 22% rise from the previous year.
    • Conclusion: Increased prevalence of secondary immunodeficiency diseases drives market growth.

    Rising Neurological Disorders

    Contribution to Market Expansion

    • Neurological Disorders: Includes conditions like Alzheimer’s, ALS, brain tumors, etc.
    • Increasing Factors: Aging populations, environmental toxins, genetic predispositions, lifestyle changes.
    • Therapeutic Benefits:
      • Modulates immune response.
      • Reduces inflammation.
      • Stabilizes neuromuscular junctions.
      • Slows disease progression and improves symptoms.
    • Example:
      • Alzheimer’s Association Report (March 2022): 6.5 million Americans aged 65 and older living with Alzheimer’s dementia, projected to reach 13.8 million by 2060.
    • Conclusion: Rising neurological disorders contribute to market growth.

    Major Players in the Subcutaneous Immunoglobulin Market

    Key Companies

    • Major Companies:
      • Pfizer Inc.
      • Johnson & Johnson.
      • Prothena Corporation plc.
      • GlaxoSmithKline plc.
      • Takeda Pharmaceutical Company Limited.
      • Amgen Inc.
      • Baxter International Inc.
      • CSL Behring.
      • Lonza Group.
      • Grifols S.A.
      • Octapharma AG.
      • Dr. Reddy’s Laboratories.
      • Intas Pharmaceutical Ltd.
      • Emergent BioSolutions Inc.
      • Bharat Serums and Vaccines Limited (BSV).
      • Kamada Pharmaceuticals.
      • CinnaGen Co.
      • Shire plc.

    Advancements in SCIG Therapy for Primary Immunodeficiency Diseases

    Innovative Products and Treatments

    • Subcutaneous Human-klhw: A unique formulation for treating primary immunodeficiency diseases.
    • Example:
      • Grifols S.A. (March 2022): Launched XEMBIFY 20% SCIG, designed for primary immunodeficiency.
      • Features:
        • Ready-to-use formulation.
        • Simplifies treatment process.
        • Increases patient convenience.
        • Stable at room temperature for up to 24 months.

    Market Segmentation

    Product Types and Applications

    • By Product Type:
      • Immunoglobulin A (IgA).
      • Immunoglobulin G (IgG).
      • Immunoglobulin M (IgM).
    • By Application:
      • Primary Immunodeficiency Disorders.
      • Autoimmune Diseases.
      • Neurological Disorders.
      • Other Applications.
    • By End-Use:
      • Clinics.
      • Hospitals.
      • Homecare.
      • Other End-Uses.

    Regional Insights

    Geographic Market Dynamics

    • Largest Region (2023): North America.
    • Fastest-Growing Region (Forecast Period): Asia-Pacific.

    The subcutaneous immunoglobulin market is set for continued growth, driven by increasing prevalence of various disorders and advancements in therapy and drug delivery systems.

    Request A Sample Of The Global Subcutaneous Immunoglobulin (SCIG) Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15935&type=smp

  • Understand How The Sterile Tubing Welder Market Is Poised To Grow Through 2024-2033

    Understand How The Sterile Tubing Welder Market Is Poised To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Sterile Tubing Welder Global Market Report 2024, the sterile tubing welder market is expected to show significant growth in the forecast period.

    Market Growth Trends

    • Recent Growth:
      • The sterile tubing welder market grew from $2.19 billion in 2023 to $2.34 billion in 2024.
      • This growth represents a compound annual growth rate (CAGR) of 6.7%.
      • Growth drivers:
        • Innovations in medical devices.
        • Increased demand for biopharmaceuticals.
        • Stringent regulatory standards.
        • Rise in chronic diseases.
        • Globalization of healthcare.
    • Future Projections:
      • Expected to reach $3.05 billion in 2028.
      • Anticipated CAGR of 6.9%.
      • Forecast growth factors:
        • Growing biotechnology sector.
        • Rapid expansion of the pharmaceutical industry.
        • Increasing focus on patient safety.
        • Emergence of advanced materials.
        • Shift towards automation and robotics.
      • Major trends:
        • Adoption of single-use systems.
        • Integration of automation and robotics.
        • Development of advanced sterilization technologies.
        • Expansion of bioprocessing capabilities.
        • Emphasis on eco-friendly and sustainable solutions.

    View More On The Sterile Tubing Welder Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sterile-tubing-welder-global-market-report

    Surging Pipeline of Biologics Fuels Market Growth

    • Driving Factors:
      • Growing biologics pipeline propels market growth.
      • Biologics include medicinal products derived from living organisms, such as vaccines, blood components, gene therapies, tissues, and recombinant proteins.
      • Advances in biotechnology and understanding of disease mechanisms drive biologics expansion.
      • Sterile tubing welders ensure aseptic connections for fluid transfer systems, critical for maintaining product purity.
      • Example: In 2023, the FDA approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), a 50% increase from 2022.

    Rising Prevalence of Chronic Diseases

    • Driving Factors:
      • Increasing chronic diseases propel market growth.
      • Chronic diseases are long-lasting, slow-progressing health conditions requiring ongoing medical attention.
      • Rise in chronic diseases due to aging populations, unhealthy lifestyles, environmental factors, and improved detection and diagnosis.
      • Sterile tubing welders produce contamination-free delivery systems for intravenous therapies and other sterile treatments.
      • Example: In 2021, chronic kidney disease accounted for approximately 20,000 fatalities in Australia, representing 12% of the total mortality rate.

    Key Market Players

    • Major Companies:
      • GE Healthcare
      • Terumo BCT Inc.
      • Sartorius AG
      • Entegris Inc.
      • Racer Technology
      • Hangzhou Wu Zhou Medical Equipment
      • Vesta Pharmaceuticals
      • MGA Technologies
      • Aseptic Group
      • Sunbelt Technology
      • Genesis BPS
      • Biomen Biosystems Co. Ltd.
      • Sentinel Process Systems Inc.
      • AdvantaPure

    Innovative Connectors Revolutionize Sterile Tubing Welding

    • Product Development:
      • Companies are developing innovative products, like genderless connectors, to simplify sterile connections and disconnections.
      • Genderless connectors allow quick and easy sterile connections without needing specific male or female components.
      • Example: In June 2022, CPC launched the AseptiQuik G DC Series Connector, enhancing closed-system liquid processing for biopharmaceutical manufacturers with quick, aseptic connections and disconnections.

    Market Segmentation

    • By Mode:
      • Manual
      • Automatic
    • By Application:
      • Biopharmaceutical
      • Blood Processing
      • Diagnostic Laboratories
      • Other Applications
    • By End-Use:
      • Hospitals
      • Research Clinics
      • Blood Centers
      • Other End-Users

    Geographical Insights

    • Largest Market:
      • North America was the largest region in the sterile tubing welder market in 2023.
    • Fastest-Growing Region:
      • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

    Request A Sample Of The Global Sterile Tubing Welder Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15933&type=smp

  • Key Trends And Drivers In The Steerable Needles Market 2024

    Key Trends And Drivers In The Steerable Needles Market 2024

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Strong Market Growth in Recent Years

    • Market Size in 2023: The steerable needles market has shown impressive growth, reaching $1.47 billion in 2023.
    • Growth Rate: It is projected to grow to $1.61 billion in 2024 at a CAGR of 9.7%.
    • Historic Growth Factors: Key drivers include regulatory approvals, standardization initiatives, increased demand for minimally invasive procedures, rising prevalence of chronic diseases, expanding applications in diagnostic imaging, and a growing geriatric population.

    Rapid Growth Expected in Coming Years

    • Future Market Size: The market is expected to surge to $2.35 billion by 2028, with a CAGR of 10.0%.
    • Forecast Growth Drivers: Anticipated growth factors include the adoption of artificial intelligence in medical procedures, expansion of telemedicine and remote surgery, emerging markets, integration with imaging technologies, and development of advanced materials for better maneuverability.
    • Trends to Watch: Key trends include enhanced robotic-assisted navigation systems, miniaturization of components, incorporation of sensor technology for real-time feedback, machine learning algorithms for trajectory optimization, and smart materials for self-steering capabilities.

    Read More On The Steerable Needles Market Report 2024 – https://www.thebusinessresearchcompany.com/report/steerable-needles-global-market-report

    Increasing Minimally Invasive Procedures Drive Market Growth

    • Minimally Invasive Procedures: These procedures involve small incisions or natural body openings, reducing tissue damage and recovery time.
    • Growth Impact: Increased adoption of minimally invasive procedures is driving the market growth due to benefits like reduced recovery times, lower risk of complications, and less postoperative pain.
    • Statistical Insight: According to the American Society of Plastic Surgeons, minimally invasive procedures such as HA fillers increased from 28.78 million in 2020 to 48.83 million in 2022, and non-invasive fat reduction procedures rose from 38.65 million in 2020 to 68.29 million in 2022.

    Major Players in the Steerable Needles Market

    • Key Companies: Prominent players include Johnson & Johnson, Medtronic Plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips, Stryker Corporation, GE HealthCare Technologies, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Intuitive Surgical Inc., Smith & Nephew plc, Hologic Inc., Varian Medical Systems Inc., Coloplast A/S, Cook Medical Incorporated, Bio-Rad Laboratories Inc., Teleflex Incorporated, KARL STORZ SE & Co KG, Elekta Instrument AB, Merit Medical Systems Inc., ConMed Corporation, Penumbra Inc., AngioDynamics Inc., AprioMed Inc.

    Steerable Biopsy Needles Enhancing Precision

    • Innovative Products: Companies are developing steerable biopsy needles to improve precision in tissue sampling and accuracy of diagnoses.
    • Example: Serpex Medical’s Compass Steerable Needles received FDA 510K clearance in September 2022. These needles provide precise three-dimensional positioning for better access to lung nodules and small lesions, offering exceptional maneuverability and controlled targeting.

    Strategic Acquisitions

    • Halma’s Acquisition of IZI Medical Products: In October 2022, Halma plc acquired IZI Medical Products for £138 million ($149.9 million). This acquisition aims to enhance Halma’s healthcare sector, especially in minimally invasive diagnosis and treatment of conditions like cancer.

    Market Segmentation

    • By Type: Bevel-Tip Flexible Needles, Symmetric-Tip Needles, Tendon Actuated Tip Needles.
    • By Application: Biopsy, Tumor Ablation, Pain Management, Robotic Assisted Surgery, Other Applications.
    • By End User: Hospitals, Ambulatory Surgical Centers, Other End Users.

    Regional Insights

    • Largest Region in 2023: North America dominated the steerable needles market.
    • Fastest-Growing Region: Asia-Pacific is expected to be the fastest-growing region in the forecast period, driven by advancements in healthcare infrastructure and increasing adoption of innovative medical technologies.

    The steerable needles market is set for remarkable growth, driven by technological advancements, increasing demand for minimally invasive procedures, and strategic industry movements. With ongoing innovations and expanding applications, this market promises significant advancements in medical procedures and diagnostics.

    Request for A Sample Of The Global Steerable Needles Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=15932&type=smp

  • Growth Trajectory Of The Sequencing Consumables Market 2024-2033

    Growth Trajectory Of The Sequencing Consumables Market 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Overview

    • Exponential Growth: The sequencing consumables market has witnessed significant growth, expanding from $7.74 billion in 2023 to $9.79 billion in 2024, with a compound annual growth rate (CAGR) of 26.5%.
    • Forecasted Expansion: By 2028, the market is expected to reach $25.34 billion, continuing its upward trajectory with a CAGR of 26.8%.

    Factors Driving Market Growth

    • Historic Period Drivers:
      • Increased drug development activities
      • Rising prevalence of genetic disorders and target diseases
      • High use of miniaturized portable instruments
      • Extensive biomarker profiling
      • Demand for personalized medicine
      • Increase in cancer patients
    • Forecast Period Drivers:
      • Demand for rapid and accurate disease diagnosis
      • Adoption of real-time polymerase chain reaction (PCR)
      • Need for rapid and on-site diagnostic testing
      • Rise in infectious disease outbreaks
      • Demand for companion diagnostics

    View More On The Sequencing Consumables Market Report 2024 – https://www.thebusinessresearchcompany.com/report/sequencing-consumables-global-market-report

    Trends in the Sequencing Consumables Market

    • Technological Advancements:
      • Advanced disease detection and monitoring
      • Innovations in drug discovery
      • Advancements in target validation and biomarker identification
      • Next-generation sequencing (NGS) technologies
      • Development of lab-on-a-chip platforms
      • Advanced molecular diagnostic solutions

    Genetic Diseases Driving Market Growth

    • Prevalence and Impact:
      • Rising prevalence of genetic diseases, influenced by improved diagnostics and environmental factors.
      • Utilization of sequencing consumables in genetic disease research for DNA extraction, library preparation, sequencing, and analysis.
    • Case Example:
      • According to the Centers for Disease Control and Prevention (CDC), approximately 6,000 babies are born with Down syndrome each year in the U.S., highlighting the need for advanced genetic testing solutions.

    Key Players in the Market

    • Leading Companies:
      • Hoffmann-La Roche Ltd.
      • Thermo Fisher Scientific Inc.
      • Merck KGaA
      • Becton, Dickinson and Company
      • Agilent Technologies Inc.
      • Illumina Inc.
      • Bio-Rad Laboratories Inc.
      • QIAGEN N.V.
      • Tecan Group AG
      • BGI Genomics Co Ltd.
      • Promega Corporation
      • Abcam Limited
      • Integrated DNA Technologies Inc.
      • Takara Bio Inc.
      • Oxford Nanopore Technologies plc
      • Lexogen GmbH

    Innovative Solutions in the Market

    • Human Whole-Genome Sequencing (WGS):
      • Comprehensive analysis of an individual’s entire genome.
      • Identification of genetic variations, mutations, and biomarkers related to health and disease.
    • Recent Developments:
      • In March 2023, Illumina Inc. launched the Illumina Complete Long Read Prep- Human, compatible with NovaSeq systems, offering combined long- and short-read data on a single instrument.

    Strategic Acquisitions

    • IDT’s Acquisition of Swift Biosciences:
      • In March 2021, Integrated DNA Technologies (IDT) acquired Swift Biosciences, enhancing IDT’s NGS product line and expanding its offerings across various research fields.

    Market Segmentation

    • By Product:
      • Kits
      • Reagents
      • Accessories
    • By Platform:
      • 1st Generation Sequencing Consumables
      • 2nd Generation Sequencing Consumables
      • 3rd Generation Sequencing Consumables
    • By Application:
      • Cancer Diagnostics
      • Infectious Disease Diagnostics
      • Reproductive Health Diagnostics
      • Pharmacogenomics
      • Agrigenomics
      • Other Applications
    • By End-Use:
      • Pharmaceutical and Biotechnology Companies
      • Hospitals and Laboratories
      • Academic Research Institutes
      • Other End-Uses

    Regional Insights

    • North America: Largest market share in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region during the forecast period.

    Request A Sample Of The Global Sequencing Consumables Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15924&type=smp

  • Small Volume Parenteral Market Growth Analysis Till 2033 By The Business Research Company

    Small Volume Parenteral Market Growth Analysis Till 2033 By The Business Research Company

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Market Overview

    • Strong Growth in Recent Years: The small volume parenteral market has seen significant growth, increasing from $163.34 billion in 2023 to $177.26 billion in 2024, reflecting a CAGR of 8.5%.
    • Historic Growth Drivers: Key factors include rising chronic disease prevalence, regulatory approvals, government initiatives, pharmaceutical outsourcing, and globalization.

    Future Market Projections

    • Continued Expansion: The market is expected to reach $247.53 billion by 2028, with a CAGR of 8.7%.
    • Key Growth Factors: Future growth will be driven by the biologics market expansion, healthcare infrastructure development, increased hospitalization rates, regulatory approvals, home healthcare shift, rising healthcare investments, and global health crises.

    Trends Shaping the Market

    • Biocompatible Formulations: Increasing demand for formulations that are compatible with human tissues.
    • Patient-centric approaches: Emphasis on personalized medicine and patient-specific treatments.
    • Home Healthcare: Growth in home-based medical care solutions.
    • Manufacturing Automation: Advancements in automated production processes.
    • Therapeutic Area Expansion: Broadening of applications across various therapeutic areas.
    • Smart Pump Technologies: Integration of advanced technologies in drug delivery systems.

    Read More On The Small Volume Parenteral Market Report 2024 – https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report

    Driving Factors

    • Rising Surgery Rates: The growing number of surgeries, driven by medical advancements and an aging population, is boosting the demand for small volume parenteral solutions.
      • Use in Surgeries: These solutions are crucial for administering medications, electrolytes, and nutrients directly into the bloodstream.
      • Surgery Statistics: For example, the American Academy of Facial Plastic and Reconstructive Surgery reported 1.4 million surgical and non-surgical plastic surgeries in 2021.

    Leading Companies

    • Market Leaders: Key players include Pfizer Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, and more.
      • Innovations: Companies are focusing on innovative production systems like the Pharmatec SVP process systems.
      • Syntegon’s SVP Essential: Launched in March 2021, this system is designed for cost-efficiency and high quality in sterile manufacturing.

    Strategic Acquisitions

    • Eris Lifesciences’ Acquisition: In February 2024, Eris Lifesciences Ltd. acquired a 51% stake in Swiss Parenteral for $76.52 million, enhancing its presence in the sterile injectables market.

    Market Segmentation

    • By Type: Ampules, Vials, Prefilled Syringes.
    • By Dose Type: Single Dose, Multiple Dose.
    • By Indication Type: Pain Management, Cancer Care, Malnourishment, Gastrointestinal Disorder Or Diarrhea, Diabetes, Other Indications.
    • By Application: Local Anesthetics, Vaccines, Other Applications.
    • By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users.

    Regional Insights

    • North America: Largest market region in 2023.
    • Asia-Pacific: Expected to be the fastest-growing region in the forecast period.

    The small volume parenteral market continues to evolve, driven by technological advancements, strategic acquisitions, and a growing demand for efficient and effective drug delivery solutions.

    Request for A Sample Of The Global Small Volume Parenteral Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=15925&type=smp

  • What’s The Growth Forecast For Spatial Omics Market Through 2024-2033?

    What’s The Growth Forecast For Spatial Omics Market Through 2024-2033?

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Current Market Overview

    • The spatial omics market is expanding swiftly.
    • 2023 Market Size: $0.27 billion.
    • 2024 Market Size: Expected to reach $0.3 billion, with a CAGR of 11.3%.
    • Growth Drivers:
      • Rising number of genetic disorders.
      • Increasing prevalence of cancer.
      • Growing demand for personalized medicine.
      • Rising need for biomarker identification and validation.
      • Increased adoption of spatial genomics, transcriptomics, and proteomics.

    Future Market Projections

    • The market is set for continued significant growth.
    • 2028 Market Size: Expected to reach $0.46 billion, with a CAGR of 11.5%.
    • Growth Drivers:
      • Increased research and development activities.
      • Increased financing for OMICS research.
      • Development of transformational approaches for cancer biomarker discovery.
      • Increased translational research.
      • Economic growth.
    • Major Trends:
      • Strategic collaborations and partnerships.
      • Advancements in spatial omics techniques.
      • Integration of advanced technologies.
      • Product innovations.
      • Technological advancements.

    View More On The Spatial omics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/spatial-omics-global-market-report

    Rising Prevalence of Genetic Illnesses Drives Market Growth

    Genetic Diseases and Market Impact

    • Genetic Diseases: Disorders caused by DNA abnormalities inherited from parents.
    • Increasing Factors: Improved diagnostic techniques, lifestyle changes, environmental factors.
    • Impact: Spatial omics technologies provide detailed spatial maps of molecular and genetic features within tissues.
    • Example:
      • WHO Report (February 2023): Congenital diseases caused an estimated 240,000 baby deaths globally within 28 days of birth each year.
      • CDC Report: About 6,000 babies are born with Down syndrome in the US each year, approximately 1 in every 700 babies.
    • Conclusion: Rising prevalence of genetic illnesses drives market growth.

    Innovations in Spatial Omics Technologies

    Technological Advancements

    • New Platforms: Companies are developing innovative spatial omics platforms to enhance market position.
    • Example:
      • Rebus Biosystems Inc. (March 2021): Launched the Rebus Esper spatial omics platform.
        • Utilizes Synthetic Aperture Optics (SAO) technology.
        • Delivers high-throughput, quantitative, single-molecule, single-cell data with spatial context and subcellular resolution.
        • Enhances spatial analysis depth and accuracy.

    Strategic Acquisitions and Collaborations

    Bruker Corporation and NanoString Technologies Inc.

    • Acquisition Details:
      • Bruker Corporation: Acquired NanoString Technologies Inc. for approximately $392.6 million in cash (May 2024).
      • Purpose: Expand spatial biology portfolio by adding gene expression profiling and spatial transcriptomics solutions.
      • Impact: Strengthens Bruker’s position in the spatial omics market.

    Market Segmentation

    Product Types and Applications

    • By Product:
    • By Sample Type:
      • Formalin-Fixed Paraffin-Embedded (FFPE).
      • Fresh Frozen.
    • By Workflow:
      • Sample Preparation.
      • Instrumental Analysis.
      • Data Analysis.
    • By Technology:
      • Spatial Transcriptomics.
      • Spatial Genomics.
      • Spatial Proteomics.
    • By End-Use:
      • Academic and Translational Research Institutes.
      • Pharmaceutical and Biotechnology Companies.

    Regional Insights

    Geographic Market Dynamics

    • Largest Region (2023): North America.
    • Fastest-Growing Region (Forecast Period): Asia-Pacific.

    The spatial omics market is set for continued growth, driven by rising prevalence of genetic illnesses, advancements in technologies, and strategic acquisitions. With increasing research activities and technological innovations, the market is poised for substantial development in the coming years.

    Request A Sample Of The Global Spatial omics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15927&type=smp

  • Top 5 Insights From The Spine Biologics Market Report 2024

    Top 5 Insights From The Spine Biologics Market Report 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Spine Biologics Global Market Report 2024, the spine biologics market is expected to show promising growth in the forecast period.

    Robust Market Growth in Recent Years

    • Market Size in 2023: The spine biologics market has seen significant growth, reaching $2.24 billion in 2023.
    • Growth Rate: It is projected to grow to $2.36 billion in 2024 at a CAGR of 5.3%.
    • Historic Growth Drivers: Key factors include advancements in biotechnology, an aging population, a high incidence of spinal disorders, increased preference for minimally invasive procedures, high awareness about spine health, improvements in diagnostic techniques, and enhanced healthcare infrastructure.

    Strong Growth Expected in Coming Years

    • Future Market Size: The market is expected to grow to $2.91 billion by 2028, with a CAGR of 5.4%.
    • Forecast Growth Drivers: Anticipated growth factors include technological innovations, increasing adoption of regenerative medicine, rising investment in R&D, growing prevalence of obesity and sedentary lifestyles, expanding healthcare access in emerging markets, favorable regulatory approvals, and increasing industry collaborations and partnerships.
    • Trends to Watch: Key trends include the emergence of novel regenerative therapies, integration of artificial intelligence in treatment planning, expansion of personalized medicine approaches, adoption of 3D printing for customized implants, and development of bioengineered scaffolds for enhanced tissue regeneration.

    View More On The Spine Biologics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/spine-biologics-global-market-report

    Rising Number of Road Accidents Drives Market Growth

    • Impact of Road Accidents: The rising number of road accidents globally is expected to propel the growth of the spine biologics market due to the need for advanced medical interventions for spinal injuries.
    • Statistics: According to the National Highway Traffic Safety Administration, an estimated 42,915 people died in motor vehicle traffic crashes in 2021 in the US, marking a 10.5% rise from the 38,824 fatalities in 2020.
    • Role of Spine Biologics: Spine biologics play a crucial role in improving patient outcomes by enhancing spinal fusion, speeding up healing, lowering surgical risks, improving pain management, and reducing the need for revision operations.

    Major Players in the Spine Biologics Market

    • Key Companies: Notable players include Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC, Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc., Aziyo Biologics, Amedica Corporation.

    Innovative Synthetic Bioactive Bone Grafts for Spinal Fusion Procedures

    • Advanced Products: Companies are developing synthetic bioactive bone grafts to better serve patients and gain a competitive edge in the market.
    • Example: In February 2022, Orthofix Medical Inc. launched Opus BA, a synthetic bioactive bone graft for cervical and lumbar spine fusion procedures. This product acts as a scaffold for bone growth, is reabsorbed and replaced by natural bone, and features an osteoconductive matrix made from carbonate apatite bone mineral, bioactive glass, and Type 1 collagen.

    Xtant Medical’s Strategic Acquisition

    • Acquisition Details: In August 2023, Xtant Medical acquired certain assets and liabilities of Surgalign Holdings Inc.’s biologics and spinal fixation products. This acquisition aims to expand Xtant Medical’s product portfolio and market presence in the orthopedic and spine surgery sectors.

    Market Segmentation

    • By Product: Bone Allografts, Bone Graft Substitutes, Platelet Rich Plasma, Bone Marrow Aspirate Therapy.
    • By Surgery Type: Anterior Cervical Discectomy and Fusion (ACDF), Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types.
    • By Application: Spinal Fusion, Spinal Non-Union and Fracture Repair, Degenerative Disc Disease Treatment, Other Applications.
    • By End User: Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users.

    Regional Insights

    • Largest Region in 2023: North America was the largest region in the spine biologics market.
    • Fastest-Growing Region: Asia-Pacific is expected to be the fastest-growing region in the forecast period, driven by advancements in healthcare infrastructure and increasing adoption of innovative medical technologies.

    The spine biologics market is poised for steady growth, driven by technological advancements, increasing demand for minimally invasive procedures, and strategic industry movements. With ongoing innovations and expanding applications, this market promises significant improvements in spinal health and patient outcomes.

    Request A Sample Of The Global Spine Biologics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15928&type=smp